Literature DB >> 29130567

Treatment strategies in coronary microvascular dysfunction: A systematic review of interventional studies.

Hannah E Suhrs1, Marie M Michelsen1, Eva Prescott1.   

Abstract

CMD has been associated with a wide spectrum of diseases and conditions, and it has proven to be a strong prognostic marker of morbidity and mortality. Despite increased attention, guideline-based treatment recommendations are lacking. We performed a systematic review of pharmacological and nonpharmacological interventions to improve coronary perfusion, assessed by IC Doppler, TTDE, PET, CMRI, transthoracic contrast perfusion echocardiography, and dilution techniques. No restrictions were made regarding the study design (randomized, placebo-controlled/randomized with active comparators/nonrandomized with or without a control group), the cardiac condition studied, or the coronary microvascular function at baseline. An electronic database search yielded 4485 records of which 80 studies met our inclusion criteria. Included studies were sorted according to intervention and study design. Studies were small and heterogeneous in methodology, and only few were placebo-controlled. Although some treatments looked promising, we found that no specific treatment was sufficiently well documented to be recommended in any patient groups. There is a need for larger well-designed clinical trials, and we suggest that future studies stratify study populations according to pathogenic mechanisms, thereby investigating whether an individualized treatment approach would be more successful.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  coronary flow velocity reserve; coronary microvascular function; myocardial perfusion; therapy

Mesh:

Year:  2019        PMID: 29130567     DOI: 10.1111/micc.12430

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  6 in total

1.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

Authors:  Vijay Kunadian; Alaide Chieffo; Paolo G Camici; Colin Berry; Javier Escaned; Angela H E M Maas; Eva Prescott; Nicole Karam; Yolande Appelman; Chiara Fraccaro; Gill Louise Buchanan; Stephane Manzo-Silberman; Rasha Al-Lamee; Evelyn Regar; Alexandra Lansky; J Dawn Abbott; Lina Badimon; Dirk J Duncker; Roxana Mehran; Davide Capodanno; Andreas Baumbach
Journal:  Eur Heart J       Date:  2020-10-01       Impact factor: 29.983

2.  Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.

Authors:  Scott M Brown; Alex I Meuth; J Wade Davis; R Scott Rector; Shawn B Bender
Journal:  Pharmacol Res       Date:  2018-06-02       Impact factor: 7.658

Review 3.  Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.

Authors:  Daria Frestad Bechsgaard; Eva Prescott
Journal:  Curr Atheroscler Rep       Date:  2021-07-16       Impact factor: 5.113

4.  Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial.

Authors:  Marie Mide Michelsen; Anna Bay Rask; Elena Suhrs; Kristoffer Flintholm Raft; Nis Høst; Eva Prescott
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

Review 5.  Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review.

Authors:  Balaj Rai; Janki Shukla; Timothy D Henry; Odayme Quesada
Journal:  Cells       Date:  2021-05-08       Impact factor: 7.666

6.  Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve.

Authors:  Jingwen Yong; Jinfan Tian; Xueyao Yang; Haoran Xing; Yi He; Xiantao Song
Journal:  Front Cardiovasc Med       Date:  2020-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.